These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12764672)

  • 41. Gemcitabine and vinorelbine as first-line chemotherapy for advanced non-small cell lung cancer: a phase II trial.
    Laack E; Mende T; Benk J; Chemaissani A; Scholtze J; Lorenz C; Niestroy A; Dalhoff K; Müller T; Walter T; Dürk H; Edler L; Hossfeld DK
    Eur J Cancer; 2001 Mar; 37(5):583-90. PubMed ID: 11290433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sequential chemotherapy of cisplatin and vinorelbine followed by paclitaxel and gemcitabine in advanced non-small-cell lung cancer. A single institution phase II study.
    Dongiovanni D; Fissore C; Berruti A; Buffoni L; Addeo A; Barone C; Polimeni MA; Ottaviani D; Bertetto O; Dongiovanni V
    Lung Cancer; 2005 Feb; 47(2):269-75. PubMed ID: 15639726
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Capecitabine and vinorelbine in elderly patients (> or =65 years) with metastatic breast cancer: a phase I trial (SAKK 25/99).
    Hess D; Thürlimann B; Pagani O; Aebi S; Rauch D; Ballabeni P; Rufener B; Castiglione-Gertsch M; Goldhirsch A;
    Ann Oncol; 2004 Dec; 15(12):1760-5. PubMed ID: 15550580
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gemcitabine and Vinorelbine Combination Chemotherapy in Taxane-Pretreated Patients with Metastatic Breast Cancer: A Phase II Study of the Kinki Multidisciplinary Breast Oncology Group (KMBOG) 1015.
    Yamamura J; Masuda N; Yamamoto D; Tsuyuki S; Yamaguchi M; Tanaka S; Tsurutani J; Tokunaga S; Yoshidome K; Mizutani M; Aono T; Ooe A; Tanino H; Matsunami N; Yasojima H; Nakayama T; Nishida Y
    Chemotherapy; 2017; 62(5):307-313. PubMed ID: 28605730
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A Phase II Randomized Study of Lapatinib Combined With Capecitabine, Vinorelbine, or Gemcitabine in Patients With HER2-Positive Metastatic Breast Cancer With Progression After a Taxane (Latin American Cooperative Oncology Group 0801 Study).
    Gómez HL; Neciosup S; Tosello C; Mano M; Bines J; Ismael G; Santi PX; Pinczowski H; Nerón Y; Fanelli M; Fein L; Sampaio C; Lerzo G; Capó A; Zarba JJ; Blajman C; Varela MS; Martínez-Mesa J; Werutsky G; Barrios CH
    Clin Breast Cancer; 2016 Feb; 16(1):38-44. PubMed ID: 26642810
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Triplet chemotherapy with vinorelbine, gemcitabine, and cisplatin for advanced non-small cell lung cancer: a phase II study.
    Niho S; Kubota K; Goto K; Ohmatsu H; Matsumoto T; Kakinuma R; Nishiwaki Y
    Br J Cancer; 2002 Dec; 87(12):1360-4. PubMed ID: 12454762
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomized phase 2 study of irinotecan plus cisplatin versus gemcitabine plus vinorelbine as first-line chemotherapy with second-line crossover in patients with advanced nonsmall cell lung cancer.
    Han JY; Lee DH; Song JE; Lee SY; Kim HY; Kim HT; Lee JS
    Cancer; 2008 Jul; 113(2):388-95. PubMed ID: 18484595
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pilot phase II study of gemcitabine and vinorelbine in patients with recurrent or refractory small cell lung cancer.
    Dudek AZ; Leśniewski-Kmak K; Bliss RL; Brunstein C; Condon DL; Kratzke RA
    Lung; 2005; 183(1):43-52. PubMed ID: 15793666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gemcitabine and vinorelbine followed by weekly docetaxel in patients with advanced non-small-cell lung cancer: a phase II trial of sequential chemotherapy.
    Cobo Dols M; Villar Chamorro E; Alés Díaz I; Gil Calle S; Alcalde García J; Gutiérrez Calderón V; Carabantes Ocón F; Montesa Pino A; Bretón García JJ; Benavides Orgaz M
    Clin Transl Oncol; 2006 Oct; 8(10):742-9. PubMed ID: 17074673
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Phase II study of oral vinorelbine in combination with capecitabine as second line chemotherapy in metastatic breast cancer patients previously treated with anthracyclines and taxanes.
    Jones A; O'Brien M; Sommer H; Nowara E; Welt A; Pienkowski T; Rolski J; Pham ML; Perraud K; Trillet-Lenoir V
    Cancer Chemother Pharmacol; 2010 Mar; 65(4):755-63. PubMed ID: 19669644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Second-line paclitaxel/carboplatin versus vinorelbine/carboplatin in patients who have advanced non-small-cell lung cancer pretreated with non-platinum-based chemotherapy: a multicenter randomized phase II study.
    Pallis AG; Syrigos K; Kotsakis A; Karachaliou N; Polyzos A; Chandrinos V; Varthalitis I; Christophyllakis C; Ardavanis A; Vamvakas L; Vardakis N; Saridaki Z; Samonis G; Giassas S; Georgoulias V; Agelaki S
    Clin Lung Cancer; 2011 Mar; 12(2):100-5. PubMed ID: 21550556
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Phase I-II study of vinorelbine in combination with 5-fluorouracil and folinic acid as first-line chemotherapy in metastatic breast cancer: a regimen with a low subjective toxic burden.
    Nolè F; de Braud F; Aapro M; Minchella I; De Pas TM; Zampino MG; Monti S; Andreoni G; Goldhirsch A
    Ann Oncol; 1997 Sep; 8(9):865-70. PubMed ID: 9358936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combination chemotherapy with gemcitabine and vinorelbine in the treatment of patients with relapsed or refractory small cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
    Hainsworth JD; Burris HA; Erland JB; Baker M; Scullin DC; Shaffer DW; Greco FA;
    Cancer Invest; 2003 Apr; 21(2):193-9. PubMed ID: 12743984
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Five-day infusion of fluorouracil and vinorelbine for advanced breast cancer patients treated previously with anthracyclines.
    Pieńkowski T; Jagiello-Gruszfeld A
    Int J Clin Pharmacol Res; 2001; 21(3-4):111-7. PubMed ID: 12067140
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gemcitabine and vinorelbine in patients with advanced lung cancer: preclinical studies and report of a phase I trial.
    Herbst RS; Lynch C; Vasconcelles M; Teicher BA; Strauss G; Elias A; Anderson I; Zacarola P; Dang NH; Leong T; Salgia R; Skarin AT
    Cancer Chemother Pharmacol; 2001 Aug; 48(2):151-9. PubMed ID: 11561781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Gemcitabine, ifosfamide and vinorelbine in advanced non-small cell lung cancer: a phase II study.
    Recchia F; Lombardo M; De Filippis S; Rosselli M; Rea S
    Anticancer Res; 2002; 22(2B):1321-8. PubMed ID: 12168945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Gemcitabine plus vinorelbine in elderly or unfit patients with non-small cell lung cancer.
    Beretta GD; Michetti G; Belometti MO; Gritti G; Quadri A; Poletti P; Labianca R
    Br J Cancer; 2000 Sep; 83(5):573-6. PubMed ID: 10944594
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phase I/II study of gemcitabine in association with vinorelbine for metastatic breast cancer.
    Mariani G; Tagliabue P; Zucchinelli P; Brambilla C; Demicheli R; Villa E; Marchianò A; Valagussa P; Bonadonna G; Gianni L
    Breast Cancer Res Treat; 2001 Dec; 70(3):163-9. PubMed ID: 11804180
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oral vinorelbine in combination with trastuzumab as a first-line therapy of metastatic or locally advanced HER2-positive breast cancer.
    Farhat F; Kattan JG; Ghosn M
    Cancer Chemother Pharmacol; 2016 May; 77(5):1069-77. PubMed ID: 27059339
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Which benefit from adding gemcitabine to vinorelbine in elderly (>or=70 years) women with metastatic breast cancer? Early interruption of a phase II study.
    Basso U; Fratino L; Brunello A; Lumachi F; De Salvo GL; Lonardi S; Ghiotto C; Koussis H; Pasetto LM; Monfardini S
    Ann Oncol; 2007 Jan; 18(1):58-63. PubMed ID: 17028243
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.